I think these are two very fair questions. I would also like to hear from the supporters of management why they think these things are the way they are? Do we simply blame the PPS on summer?
Here is another honest question. How long would supporters of this company - or those now not as supportive as they once were - continue to hold and wait to see products or revenue-producing programs happen at CYGX? I have now held this stock for I would say six to nine months after my judgment told me to sell and rebuy later at the first sign of financing or revenue. I don't know how much longer I can avoid doing this.
I still think this company is worth being a part of, but I have missed out on profits by being "patient". I'd like to hear how long supporters are going to wait, and to hear if some have sold and will rebuy at signs of life here. Thanks.
I was told by CYGX that they are ready for the first clinical trial of herpes cream but decided to wait till they have enough financing. They don't want to start the clinical trial and have to stop as result of lack of finance. They are hoping for revenues when they sell their synthetic DNA.
Market Data 
Markets 
AI
